Karuna Therapeutics (KRTX) Stock Forecast & Price Prediction

Estimation of the future price movement of Karuna Therapeutics stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target

Current $329.83

Concensus $257.50

Low $150.00

Median $272.50

High $330.00

Based on analysts projections #KRTX is expected to experience a price decline over the next year.

The current average KRTX price target, as estimated by these analysts, is $257.50.

The predictions for the future KRTX stock price range from a low of $150.00 to a high of $330.00, highlighting the variability of market expectations for KRTX.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

KRTX stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Raghuram Selvaraju
H.C. Wainwright
December 26, 2023 Buy 330.00 317.00
Piper Sandler January 5, 2023 Sell 285.00 198.46
Yatin Suneja
August 12, 2022 Buy 330.00 261.31
Paul Matteis
Stifel Nicolaus
August 8, 2022 Sell 260.00 241.19
Mizuho Securities April 27, 2022 Sell 190.00 120.50
Jason McCarthy
Maxim Group
August 5, 2021 Sell 150.00 117.81

Karuna Therapeutics (KRTX) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if Karuna Therapeutics is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.


Financial Scores

Updated on: 15/04/2024

Altman Z-Score: 91.1

Piotroski Score: 1.0

ESG Score

Updated on: 15/04/2024

Environmental: 62.7

Social: 66.9

Governance: 61.8

Financial Health

Updated on: 15/04/2024

DCF: Neutral

ROE: Sell

ROA: Neutral

Debt to equity ratio: Sell

Price to earnings ratio: Strong Sell

Price to book ratio: Strong Buy

KRTX Discounted Cash Flow

Updated on: 15/04/2024

Discounted Cash Flow Value

Current Price

KRTX Revenues by Segment

Updated on: 15/04/2024

No available data

Revenue from Contract with Customer, Excluding Assessed Tax

KRTX Revenues by Region

Updated on: 15/04/2024

No available data

KRTX Notes Due

Updated on: 15/04/2024


There are no data to display

Karuna Therapeutics (KRTX) Social Sentiments

Monitoring bullish and bearish sentiments towards Karuna Therapeutics on Twitter and Stocktwits could help to forecast an upward or downward trend in Karuna Therapeutics stock price.

No social results for KRTX

Karuna Therapeutics Stock Forecast: Promising Drug Pipeline Poised for High-Growth Potential

Karuna Therapeutics (KRTX) is a biotechnology company that focuses on developing innovative therapies for neuropsychiatric disorders. The company has been making headlines in the biotech world due to its promising drug pipeline, and investors are taking notice. Currently trading at around $85 per share, Karuna Therapeutics holds a market capitalization of approximately $2.8 billion. The stock has had an impressive... Read more

Karuna Therapeutics: Innovative Biotech Leader with Promising Stock Predictions in Brain Disorder Treatment

The biotechnology stock market sector has experienced significant growth in recent years, attracting investors seeking high-potential returns. Biotechnology stocks are expected to benefit from significant advances in medical research and technology. One of the companies that have been making waves in this industry is Karuna Therapeutics (stock ticker Biotechnology). It has proven to be a formidable player in the biotech... Read more